Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical drug investigation 2023, Vol.43 (1), p.83-84
Hauptverfasser: Grossi, Julia Diniz, Surjan, Juliana, Delfino, Rodrigo Simonini, Del Porto, Jose Alberto, Lacerda, Acioly Luiz Tavares
Format: Artikel
Sprache:eng
Schlagworte:
Bipolar Disorder - drug therapy
Depressive Disorder, Major - drug therapy
Humans
Internal Medicine
Ketamine - adverse effects
Letter to the Editor
Medicine
Medicine & Public Health
Pharmacology/Toxicology
Pharmacotherapy
Suicide
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1173-2563
1179-1918
DOI:10.1007/s40261-022-01223-w